Literature DB >> 4027882

Erythema nodosum heralding recurrent Hodgkin's disease.

S Simon, S J Azevedo, J J Byrnes.   

Abstract

The association of erythema nodosum with Hodgkin's disease is acknowledged, although not well-documented in the literature. Two patients with long remissions of their Hodgkin's disease manifested persistent erythema nodosum beginning 7 and 6 months, respectively, before relapse was clinically evident. The skin lesions in both patients partially responded to treatment with indomethacin, but did not resolve completely until chemotherapy was instituted. Erythema nodosum probably reflects an important change in the balance of biologic forces between the host and the neoplasm, the nature of which can only be speculated upon at this time. Erythema nodosum should be considered a warning signal of impending relapse in a patient with a history of Hodgkin's disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4027882     DOI: 10.1002/1097-0142(19850915)56:6<1470::aid-cncr2820560641>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

Review 1.  Recognizing unusual manifestations of Hodgkin lymphoma.

Authors:  Nicholas A Barber; Philip J Bierman
Journal:  Curr Hematol Malig Rep       Date:  2012-09       Impact factor: 3.952

Review 2.  Erythema nodosum and Hodgkin's disease.

Authors:  B Taillan; E Ferrari; J G Fuzibet; H Vinti; A Pesce; P Dujardin
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

3.  Erythema nodosum as a presenting feature of T-cell-rich B-cell lymphoma.

Authors:  J T Navarro; J M Ribera; M Vaquero; E Tuset; J Juncá; F Millá; E Feliu
Journal:  Ann Hematol       Date:  1995-02       Impact factor: 3.673

Review 4.  Erythema nodosum - review of the literature.

Authors:  Małgorzata Chowaniec; Aleksandra Starba; Piotr Wiland
Journal:  Reumatologia       Date:  2016-06-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.